Temozolomide in combination with fotemustine in patients with metastatic melanomaTAS, Faruk; CAMLICA, Hakan; TOPUZ, Erkan et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 2, pp 293-298, issn 0344-5704, 6 p.Article

Antimutagenicity of amifostine against the anticancer drug fotemustine in the Drosophila somatic mutation and recombination (SMART) testAYDEMIR, N; SEVIM, N; CELIKLER, S et al.Mutation research. Genetic toxicology and environmental mutagenesis (Print). 2009, Vol 679, Num 1-2, pp 1-5, issn 1383-5718, 5 p.Article

Nouvelle toxicité de la fotémustine: une pneumopathie interstitielle diffuse = New toxicity of fotemustine: Diffuse interstitial lung diseaseBERTRAND, M; WEMEAU-STERVINOU, L; GAUTHIER, S et al.Annales de dermatologie et de vénéréologie. 2012, Vol 139, Num 4, pp 277-281, issn 0151-9638, 5 p.Article

Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer GroupAAPRO, M. S; VAN WIJK, F. H; SPLINTER, T. E. W et al.European journal of cancer (1990). 2003, Vol 39, Num 8, pp 1141-1143, issn 0959-8049, 3 p.Article

Functional and morphological effects of fotemustine on the auditory system of the ratGOCER, C; ERYILMAZ, A; KAYIKCI, M. E. Kulak et al.Journal of laryngology and otology. 2008, Vol 122, Num 6, pp 551-556, issn 0022-2151, 6 p.Article

Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patientsDUMONTET, C; JAUBERT, J; SEBBAN, C et al.Annals of oncology. 2003, Vol 14, Num 4, pp 615-622, issn 0923-7534, 8 p.Article

Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: A phase III studyAVRIL, M. F; AAMDAL, S; PORTA, V. Guillem et al.Journal of clinical oncology. 2004, Vol 22, Num 6, pp 1118-1125, issn 0732-183X, 8 p.Article

Fotemustine and interferon α2b in metastatic malignant melanomaWEICHENTHAL, M; MOHR, P; STEPHAN, U et al.Journal of cancer research and clinical oncology. 1998, Vol 124, Num 1, pp 55-59, issn 0171-5216Article

Apport d'une nouvelle nitroso-urée : la fotémustine = Activity of a new nitrourea: fotemustinBOAZIZ, C.Pathologie et biologie. 1992, Vol 40, Num 9BIS, pp 964-968, issn 0369-8114Article

Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapyLEYVRAZ, S; SPATARO, V; BAUER, J et al.Journal of clinical oncology. 1997, Vol 15, Num 7, pp 2589-2595, issn 0732-183XArticle

Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide : Modulation of proto-oncogene expressionKERN, M. A; HELMBACH, H; ARTUC, M et al.Anticancer research. 1997, Vol 17, Num 6D, pp 4359-4370, issn 0250-7005Article

Immunochemotherapie des metastasierenden Uvea-melanoms mit Interferon-α2b, Interleukin-2 und Fotemustin Kasuistiken und Literaturübersicht = Imunochemotherapy of metastastic uveal melanoma with interferon-α2b, interleukin-2, and fotemustine :case reports and literature reviewTERHEYDEN, P; KÄMPGEN, E; RÜNGER, T. M et al.Hautarzt. 1998, Vol 49, Num 10, pp 770-773, issn 0017-8470Article

Fotémustine : Muphoran® = Fotemustin : Muphoran®AVRIL, M.-F.Annales de dermatologie et de vénéréologie. 2007, Vol 134, Num 12, pp 997-1000, issn 0151-9638, 4 p.Article

Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene MGMTCHRISTMANN, Markus; PICK, Matthias; LAGE, Hermann et al.International journal of cancer. 2001, Vol 92, Num 1, pp 123-129, issn 0020-7136Article

DNA damage induced by fotemustine in cultured HL60 cellsSHOU, J; FENG, X.-W.Zhōngguó yàoli xuébào. 1996, Vol 17, Num 5, pp 474-477, issn 0253-9756Article

Fotemustine Chemoembolization of Hepatic Metastases From Uveal Melanoma: A Retrospective Single-Center AnalysisEDELHAUSER, Gundula; SCHICHER, Nikolaus; BERZACZY, Dominik et al.American journal of roentgenology (1976). 2012, Vol 199, Num 6, pp 1387-1392, issn 0361-803X, 6 p.Article

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiformeFAZENY-DÖRNER, B; VEITL, M; WENZEL, C et al.British journal of cancer. 2003, Vol 88, Num 4, pp 496-501, issn 0007-0920, 6 p.Article

Artesunate in the treatment of metastatic uveal melanoma : first experiencesBERGER, Thomas G; DIECKMANN, Detlef; EFFERTH, Thomas et al.Oncology reports. 2005, Vol 14, Num 6, pp 1599-1603, issn 1021-335X, 5 p.Article

Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II studyBEAUCHESNE, Patrick D; TAILLANDIER, L; BERNIER, V et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 1, pp 171-175, issn 0344-5704, 5 p.Article

Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma : experience in 101 patientsPETERS, S; VOELTER, V; KEILHOLZ, U et al.Annals of oncology. 2006, Vol 17, Num 4, pp 578-583, issn 0923-7534, 6 p.Article

Synthesis and biological evaluation of Fotemustine analogues on human melanoma cell linesWINUM, Jean-Yves; BOUISSIERE, Jean-Luc; PASSAGNE, Isabelle et al.European journal of medicinal chemistry. 2003, Vol 38, Num 3, pp 319-324, issn 0223-5234, 6 p.Article

Stability study of fotemustine in PVC infusion bags and sets under various conditions using a stability-indicating high-performance liquid chromatographic assayDINE, T; KHALFI, F; GRESSIER, B et al.Journal of pharmaceutical and biomedical analysis. 1998, Vol 18, Num 3, pp 373-381, issn 0731-7085Article

Twice-daily Dosing of Temozolomide in Combination with Fotemustine for the Treatment of Patients with Refractory GlioblastomaSANTONI, M; PACCAPELO, A; BURATTINI, L et al.Anticancer research. 2012, Vol 32, Num 3, pp 1099-1101, issn 0250-7005, 3 p.Article

Initial Experience with Hepatic Intraarterial Fotemustine and Interferon Alpha 2b Combination for Treatment of Liver TumorsVITO VITALE, Felice; ROMEO, Placido; DI MAGGIO, Enrico Maria et al.Anticancer research. 2011, Vol 31, Num 12, pp 4553-4559, issn 0250-7005, 7 p.Article

La fotémustine dans l'indication mélanome malin métastatique : analyse globale des résultatsPathologie et biologie. 1990, Vol 38, Num 8, pp 876-880, issn 0369-8114Article